Pharmaceuticals, Biotechnology and Life Sciences
European site enrollment concerns grow to 85% NORTHBROOK, Ill.–(BUSINESS WIRE)–#COVID19–Over the course of just one week, US clinical research study…
The U.S. Food and Drug Administration is actively and aggressively monitoring the market for any firms marketing products with fraudulent coronavirus (COVID-19) diagnostic, prevention and treatment claims as part of our ongoing efforts to protect public health during this pandemic. As a result of these activities, the agency is beginning to see unauthorized fraudulent test kits that are being marketed to test for COVID-19 in the home.
Merck said on Tuesday it got top-line efficacy results from two its pivotal Phase 3 trials (COUGH-1 and COUGH-2) testing…
John Butler, the President and Chief Executive Officer sent a message about precautions to help mitigate the spread of COVID-19…
The COVID-19 crisis continues to evolve rapidly and in recent days several governments in the markets in which Unibail-Rodamco-Westfield (“URW”)…
The World Health Organisation has issued a guideline to keep safety in schools. We have outlined the most important keys…
American president Donald Trump has announced radical measures last week; closing entering the USA for European citizens, curbing flights in general, and has announced a national emergency. Only two weeks earlier he was skeptical about the outbreak of the coronavirus in the USA.
How do pharmaceutical companies prophet from COVID-19? Do they make the profit?
Chairman and CEO Albert Bourla Calls on Biopharma Industry to Collaborate on Combatting the Global Pandemic NEW YORK–(BUSINESS WIRE)–Pfizer today…
IBM Watson Health and EBSCO Information Services Thursday announced a strategic collaboration aimed towards enhancing clinical decision support (CDS) and operations for healthcare providers and health systems.